Indian J Pharm Close
 

Figure 2: Risk Group Stratification for Leptomeningeal Metastases Patients[3].Source: Recreated from Remon J, et al. Cancer Treat Rev 2017;53:128-137

Figure 2: Risk Group Stratification for Leptomeningeal Metastases Patients<sup>[3]</sup>.Source:  Recreated from Remon J, <i>et al</i>. Cancer Treat Rev 2017;53:128-137